pelvintense.de
Aug 6, 2025, 18:40
Sabine D. Brookman-May: Lymphovascular Invasion in Prostate Cancer: Relevant, Underreported, Underutilized
Sabine D. Brookman-May, Senior Vice President of Therapeutic Area and Head of Urologic Oncology at Aura Biosciences, shared a post on X:
“Just published in Urology Gold Journal.
Lymphovascular invasion in prostate cancer: relevant, underreported, underutilized
Let’s move LVI to a clinical decision-maker with standardized diagnostics, L1/V1 differentation, post-RP risk models + adjuvant therapy trigger.”
Title: Letter to the Editor on “Revisiting the Role of Lymphovascular Invasion in Prostate Cancer: A Narrative Review”
Authors: Matthias May, Ingmar Wolff, Maximilian Burger, Sabine Brookman-May
Read the Full Article.
More posts featuring Sabine D. Brookman-May.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 6, 2025, 22:57
Aug 6, 2025, 22:41
Aug 6, 2025, 22:14
Aug 6, 2025, 21:22
Aug 6, 2025, 21:07
Aug 6, 2025, 21:01
Aug 6, 2025, 20:49
Aug 6, 2025, 20:34